Building a Resilient Biotech Company: Management Lessons Through Capital Downturns

Supply chain shortages, rising costs, changes in the workforce, and continued macroeconomic uncertainty have impacted the industry for nearly three years.  Have strategic goals changed to match these pressures or were companies well-positioned to navigate these challenges? Attend to gain insight from experienced executives and board members about how to position your company for the future.